FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38732111000001103: Rybelsus 7mg tablets (Novo Nordisk Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1545861000001113 Rybelsus 7mg tablets (Novo Nordisk Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1545871000001115 Rybelsus 7mg tablets (Novo Nordisk Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rybelsus 7mg tablets (Novo Nordisk Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Is a Semaglutide 7mg tablets true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Is a Rybelsus true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Has specific active ingredient Semaglutide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rybelsus 7mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has AMP True Rybelsus 7mg tablets (Novo Nordisk Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start